Aglaia Therapeutics
A biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies in cancer patients.
HQ location
Villejuif, France
Launch date
Enterprise value
$18—26m
Company register number
| Date | Investors | Amount | Round |
|---|---|---|---|
€4.0m | Seed | ||
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads